Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]

© 2018 The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused.

Bibliographic Details
Main Authors: Manu, K., Shanmugam, M., Ramachandran, L., Li, F., Siveen, K., Chinnathambi, A., Zayed, M., Alharbi, S., Arfuso, Frank, Kumar, Alan Prem, Ahn, K., Sethi, G.
Format: Journal Article
Published: Elsevier 2018
Online Access:http://hdl.handle.net/20.500.11937/67036
_version_ 1848761458080350208
author Manu, K.
Shanmugam, M.
Ramachandran, L.
Li, F.
Siveen, K.
Chinnathambi, A.
Zayed, M.
Alharbi, S.
Arfuso, Frank
Kumar, Alan Prem
Ahn, K.
Sethi, G.
author_facet Manu, K.
Shanmugam, M.
Ramachandran, L.
Li, F.
Siveen, K.
Chinnathambi, A.
Zayed, M.
Alharbi, S.
Arfuso, Frank
Kumar, Alan Prem
Ahn, K.
Sethi, G.
author_sort Manu, K.
building Curtin Institutional Repository
collection Online Access
description © 2018 The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused.
first_indexed 2025-11-14T10:31:59Z
format Journal Article
id curtin-20.500.11937-67036
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:31:59Z
publishDate 2018
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-670362018-09-28T01:55:51Z Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36] Manu, K. Shanmugam, M. Ramachandran, L. Li, F. Siveen, K. Chinnathambi, A. Zayed, M. Alharbi, S. Arfuso, Frank Kumar, Alan Prem Ahn, K. Sethi, G. © 2018 The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused. 2018 Journal Article http://hdl.handle.net/20.500.11937/67036 10.1016/j.canlet.2018.01.003 Elsevier restricted
spellingShingle Manu, K.
Shanmugam, M.
Ramachandran, L.
Li, F.
Siveen, K.
Chinnathambi, A.
Zayed, M.
Alharbi, S.
Arfuso, Frank
Kumar, Alan Prem
Ahn, K.
Sethi, G.
Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
title Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
title_full Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
title_fullStr Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
title_full_unstemmed Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
title_short Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
title_sort corrigendum on “isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of nf-κb signaling cascade in gastric cancer” [cancer lett. 363 (1) (2015) 28–36]
url http://hdl.handle.net/20.500.11937/67036